These postbiotics address key limitations of current TMAU therapies: they circumvent the safety risks of live probiotics, avoid dysbiosis from antibiotics, and outperform dietary restrictions in sustainability
This involves the free thiol cysteamine, which can deplete approximately 95% of the lysosomal cystine content
Encapsulating or binding plant drugs in polymers or lipids can enhance stability, loading capacity, bioavailability, and control release
GLP-1 medications require individual dose escalation schedulestypically starting at 0.25 mg and advancing over 45 weeksto minimize nausea and gastrointestinal upset
By activating both GIP and GLP-1 receptors, tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriate glucagon release, and slows gastric emptying